Investor Relations

Listed On The Shanghai Stock Exchange In June 2001, With A Maximum Market Value Of 47.5 Billion

Rules of Procedure for Board Meetings Rules of Procedure for Shareholders' Meetings Investor Complaint Handling System

Rules of Procedure of the Board of Directors of Joincare Pharmaceutical

Time:2019-11-04

< 1 >

Rules of Procedure of the General Meeting of Shareholders

Time:2020-06-08

Rules of Procedure for the General Meeting of Shareholders of Joincare Pharmaceutical

Time:2019-11-04

< 1 >

Our company strictly follows the requirements of laws and regulations such as the "Company Law of the People's Republic of China", the "Securities Law of the People's Republic of China", the "Corporate Governance Guidelines for Listed Companies", and the "Rules for Stock Listing on the Shanghai Stock Exchange", continuously improving the company's corporate governance structure, strengthening information disclosure, improving investor relations management, continuously strengthening and improving the company's internal control, and standardizing the company's operations.